Presurgical levels of circulating cell-derived microparticles discriminate between patients with and without transfusion in coronary artery bypass graft surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 149, Issue 1, 2015, Pages 305-311

  Jy, Wenche ^a   Gómez Marín, Orlando ^b   Salerno, Tomas A ^a   Panos, Anthony L ^a   Williams, Donald ^a   Horstman, Lawrence L ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; HEMOGLOBIN; BIOLOGICAL MARKER; GLYCOPHORIN; GLYCOPROTEIN IIB; GYPA PROTEIN, HUMAN;

ADULT; ADVERSE OUTCOME; AREA UNDER THE CURVE; ARTICLE; BLOOD GROUP; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATIENT RISK; PLATELET MICROPARTICLE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RED CELL MIRCOPARTICLE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SURGICAL RISK; AGED; BLOOD; BLOOD LOSS, SURGICAL; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEM; ERYTHROCYTE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; RISK; STATISTICAL MODEL; THROMBOCYTE;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; BLOOD TRANSFUSION; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DECISION SUPPORT TECHNIQUES; ERYTHROCYTES; FEMALE; GLYCOPHORIN; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARTIAL THROMBOPLASTIN TIME; PLATELET MEMBRANE GLYCOPROTEIN IIB; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 84922311420     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.10.042     Document Type: Article

References (29)

1. Goodnough LR. Blood management: transfusion medicine comes of age. Lancet. 2013;381:1791-2.
2. Loor G, Rajeswaran J, Li L, Sabik JF III, Blackstone EH, McCrae KR, et al. The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? J Thorac Cardiovasc Surg. 2013;146:1480-7.
3. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544-52.
4. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and bloodcomponent transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608-16.
5. Bhaskkar B, Dulhunty DV, Fraser JF. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. Ann Thorac Surg. 2012;94:460-7.
6. Paone G, Brewer R, Theurer PF, Bell GF, Cogan CM, Prager RL, Michigan Society of Thoracic and Cardiovascular Surgeons. Preoperative predicted risk does not fully explain the association between red blood cell transfusion and mortality in coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012; 143:178-85.
7. La Par DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, et al; Investigators for the Virginia Cardiac Surgery Quality Initiative. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:796-803.
8. Ferranis VA, Gildengonin V. Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis. J Thorac Cardiovasc Surg. 1989;98:492-7.
9. Shehata N, Naglie G, Alghamdi AA, Callum J, Mazer CD, Hebert P, et al. Risk factors for red cell transfusion in adults undergoing coronary artery bypass surgery: a systematic review. Vox Sang. 2007;93:1-11.
10. van Straten AH, Kats S, Bekker MW, Verstappen F, ter Woorst JF, van Zundert AJ, et al. Risk factors for red cell transfusion after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24:413-7.
11. Williams JB, Phillips-Bute B, Bhattachary SD, Shah AA, Amdersen ND, Altinase B, et al. Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2011;141:283-8.
12. Karkouti K, McCluskey SA, Syed S, Pazaratz C, Poonawala H, Crowther MA. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Anesth Analg. 2010;110:1533-40.
13. Emeklibas N, Kammerer I, Bach J, Sack F, Hellstern P. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery. Transfusion. 2013;53:1226-34.
14. Wasowicz M, McCluskey SA, Wijeysundera DN, Yau TM, Meinri M, Beattie WS, et al. The incremental value of thromboelastography for prediction of excessive blood loss after cardiac surgery: An observational study. Anesth Analg. 2010;111:331-8.
15. Coakley M, Hall JE, Evans C, Duff E, Billing V, Yang L, et al. Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding. J Thromb Haemost. 2011;9: 282-92.
16. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009;101:439-51.
17. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem. 1989;264:17049-57.
18. Jy W, Johansen ME, Bidot C Jr, Horstman LL, Ahn YS. Red cell-derived microparticles (RMP) as haemostatic agent. Thromb Haemost. 2013;110:751-60.
19. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol. 1997;96:458-63.
20. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992;119:334-45.
21. Fatemi O, Torguson R, Chen F, Ahmad S, Badr S, Satler LF, et al. Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. Am Heart J. 2013;166:104-9.
22. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. Effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69: 1691-5.
23. Rand ML, Wang H, Bang KW, Packham MA, Freedman J. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost. 2006;4:1621-3.
24. Augustine D, Ayers LV, Lima E, Newton L, Lewandowski AJ, Davis EF, et al. Dynamic release and clearance of circulating microparticles during cardiac stress. Circ Res. 2014;114:109-13.
25. Schroit AJ, Madsen JW, Tanaka Y. In vivo recognition and clearance of red cells containing phosphatidylserine in the plasma membrane. J Biol Chem. 1985;265: 5131-8.
26. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release. 2002; 79:29-40.
27. Oldenborg P. Role of CD47 and signal regulatory protein alpha (SIRP alpha) in regulating the clearance of viable or aged blood cells. Trans Med Hemother. 2012;39:315-20.
28. Brück W, Friede RL. Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol. 1990;80:415-8.
29. Dasgupta SK, Le A, Chavakis T, Dasgupta SK, Le A, Chavakis T, et al. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation. 2012;125:1664-72.